Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2021, Vol. 41 Issue (4): 30-36    DOI: 10.13523/j.cb.2101031
技术与方法     
血栓调节蛋白化学发光免疫分析检测方法的建立*
李帅鹏1,任和1,安展飞2,杨艳坤1,白仲虎1,**()
1 江南大学 粮食发酵工艺与技术国家工程实验室 无锡 214122
2 江苏拜明生物技术有限公司 盐城 224005
The Development of Chemiluminescence Immunoassay Detection Method for Thrombomodulin
LI Shuai-peng1,REN He1,AN Zhan-fei2,YANG Yan-kun1,BAI Zhong-hu1,**()
1 National Engineering Laboratory of Grain Fermentation Technology, Jiangnan University, Wuxi 214122, China
2 Jiangsu Baiming Biotechnology Co., Ltd., Yancheng 224005, China
 全文: PDF(2144 KB)   HTML
摘要:

目的:建立并评价基于板式化学发光免疫分析(CLIA)平台的血栓调节蛋白(TM)定量检测方法。方法:以链霉亲和素包被微孔板,加入待检血浆,偶联生物素和辣根过氧化物酶的配对抗体组成分析体系,采用双抗体夹心模式,建立TM抗原定量检测方法,并对其进行条件优化和性能评价。结果:生物素化抗体和酶标抗体的工作浓度分别为0.5 μg/mL和0.75 μg/mL,加样后的孵育时间选为15 min,最低检测限为0.2 TU/mL,该检测方法的检测范围为1~200 TU/mL,批间和批内精密度(CV)均小于8%,37 ℃ 10天稳定性良好,207份临床血浆测值与希森美康测值相关性较高(R2>0.96)。结论:建立了TM板式化学发光定量检测方法,且各项性能指标良好,可满足临床检测的需要。

关键词: 血栓调节蛋白化学发光免疫分析检测方法性能评估    
Abstract:

Objective: To establish and evaluate a quantitative detection method for thrombomodulin (TM) based on a plate chemiluminescence immunoassay (CLIA) platform. Methods: The analysis system was composed of microplate coated with streptavidin, serum, the paired antibody coupled biotin and horseradish peroxidase. The double antibody sandwich mode was adopted to test quantitatively TM antigen. Moreover,the reaction conditions of TM were optimized and the analytical performance was evaluated. Results: The working concentration of biotinylated antibody and enzyme-labeled antibody was 0.5 μg/mL and 0.75 μg/mL, respectively. The incubation time was 15 min; the minimum detection limit was 0.2 TU/mL and the range of the detection method was 1~200 TU/mL. Inter-assay and intra-assay precision (CV) were less than 8%. The established method had good stability during 10 days at 37 ℃. 207 clinical plasma measured values had a high correlation with Sysmex measured values (R2>0.96). Conclusion: This study has successfully established a quantitative detection method of TM plate chemiluminescence, which has good performance indicators and can meet the needs of clinical detection.

Key words: Thrombomodulin    Chemiluminescence immunoassay    Detection method    Performance evaluation
收稿日期: 2021-01-25 出版日期: 2021-04-30
ZTFLH:  Q819  
基金资助: *江苏省重点研发计划资助项目(BE2018621)
通讯作者: 白仲虎     E-mail: baizhonghu@jiangnan.edu.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
李帅鹏
任和
安展飞
杨艳坤
白仲虎

引用本文:

李帅鹏,任和,安展飞,杨艳坤,白仲虎. 血栓调节蛋白化学发光免疫分析检测方法的建立*[J]. 中国生物工程杂志, 2021, 41(4): 30-36.

LI Shuai-peng,REN He,AN Zhan-fei,YANG Yan-kun,BAI Zhong-hu. The Development of Chemiluminescence Immunoassay Detection Method for Thrombomodulin. China Biotechnology, 2021, 41(4): 30-36.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2101031        https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I4/30

Biotin-AB concentration
(μg/mL)
HRP-AB concentration
(μg/mL)
0.5 0.75 1
0.5 0.75 1 0.5 0.75 1 0.5 0.75 1
标准品1的RLU 4 105 5788 9 814 7 654 11 037 14 438 9 352 13 767 16 156
标准品2的RLU 24 518 39 609 47 814 35 654 49 036 60 438 43 352 61 167 78 251
标准品3的RLU 92 711 155 834 192 167 136 761 205 767 282 706 173 866 259 202 380 207
标准品4的RLU 470 111 680 783 767 481 677 416 793 734 883 892 727 131 880 548 1 242 238
标准品5的RLU 992 165 1 581 074 1 917 085 1 3587 29 1 884 604 2 373 687 1 584 499 2 266 596 2 873 804
标准品6的RLU 2 405 635 3 409 013 3 983 793 2 922 509 3 665 265 4 365 232 3 325 649 3 975 402 4 574 529
表1  生物素化抗体和酶标抗体工作浓度
图1  不同孵育时间对标准品的影响
图2  孵育时间对样本影响
Theoretical concentration
(TU/mL)
Measured concentration (TU/mL) 偏差
重复1 重复2 重复3 重复4 重复5
质控品1 5.06 4.89 4.81 4.72 4.92 4.86 -4.3%
质控品2 119.53 124.31 125.95 124.17 122.46 123.98 3.9%
表2  准确度检测
Control 1 Control 2
Batch 1 Batch 2 Batch 3 Batch 1 Batch 2 Batch 3
平均值(TU/mL) 4.94 4.96 4.99 117.64 121.52 118.73
批内CV 4.3% 3.9% 5.9% 5.2% 5.5% 6.0%
批间CV 4.7% 5.5%
表3  质控品精密度检测
时间 Control 1 Control 2
5.12 TU/mL 121.37 TU/mL
第1天 重复1 5.14 118.75
(TU/mL) 重复2 5.16 117.63
重复3 5.21 119.27
偏差 1.0% -2.3%
第3天 重复1 5.08 116.96
(TU/mL) 重复2 5.06 115.74
重复3 5.04 114.69
偏差 -1.2% -4.6%
第6天 重复1 4.92 114.32
(TU/mL) 重复2 4.94 113.98
重复3 4.88 112.17
偏差 -4.0% -6.5%
第10天 重复1 4.75 112.32
(TU/mL) 重复2 4.69 113.98
重复3 4.71 112.17
偏差 -7.9% -7.0%
表4  加速稳定性实验结果
图3  本方法与希森美康试剂检测相关性
Performance index Manufacturer
Sysmex This study
检测范围(TU/mL) 1~200 1~200
批内CV 1.95% 6.0%
批间CV 3.25% 5.5%
最低检测限(TU/mL) 0.34 0.2
检测时间(min) 14 16
37 ℃稳定性 -5.8% -7.9%
血浆对比相关性 相关系数(R2)>0.96
表5  试剂性能对比结果
[1] Maruyama I, Bell C E, Majerus P W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. Journal of Cell Biology, 1985,101(2):363-371.
[2] 郑娜娜. 血栓调节蛋白对肺癌细胞致瘤性和迁移的抑制作用及其机制. 苏州: 苏州大学, 2016.
Zheng N N. Thrombomodulin inhibits tumorigenesis and migration of lung cancer cells and its mechanism. Suzhou: Soochow University, 2016.
[3] Morser J. Thrombomodulin links coagulation to inflammation and immunity. Current Drug Targets, 2012,13(3):421-431.
pmid: 22206250
[4] Dittman W A, Majerus P W. Structure and function of thrombomodulin: a natural anticoagulant. Blood, 1990,75(2):329-336.
[5] Conway E M. The type XIV family of C-type lectin-like domain (CTLD) containing proteins. Current Drug Targets, 2012,13(3):409-410.
pmid: 22206248
[6] Loghmani H, Conway E M. Exploring traditional and nontraditional roles for thrombomodulin. Blood, 2018,132(2):148-158.
[7] Owen W G, Esmon C T. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. The Journal of Biological Chemistry, 1981,256(11):5532-5535.
[8] Anastasiou G, Gialeraki A, Merkouri E, et al. Thrombomodulin as a regulator of the anticoagulant pathway: implication in the development of thrombosis. Blood Coagulation & Fibrinolysis, 2012,23(1):1-10.
pmid: 22036808
[9] Nishizawa S, Kikuta J, Seno S, et al. Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in vivo. Journal of Pharmacological Sciences, 2020,143(1):17-22.
pmid: 32122774
[10] 王涤非, 刘国良, 吴桂萍, 等. 糖尿病血浆血栓调节蛋白水平的测定. 中国医科大学学报, 2000,29(5):368-369.
Wang D F, Liu G L, Wu G P, et al. Measurement of soluble thrombomodulin in plasma from diabetes. Journal of China Medical University, 2000,29(5):368-369.
[11] 林静, 孙志鹏, 李娟, 等. 联合检测TM、TAT、PIC、t-PAIC水平对DIC的诊断价值. 国际检验医学杂志, 2019,40(12):1413-1416.
Lin J, Sun Z P, Li J, et al. Value of combined detection of the levels of serum TM, TAT, PIC and t-PAIC for the early diagnosis of disseminated intravascular coagulation. International Journal of Laboratory Medicine, 2019,40(12):1413-1416.
[12] Luo Y Q, Liu T, Zhu J M, et al. Label-free and sensitive detection of thrombomodulin, a marker of endothelial cell injury, using quartz crystal microbalance. Analytical Chemistry, 2015,87(22):11277-11284.
[13] 周齐洋, 黄建荣, 陈祥, 等. 血清淀粉样蛋白A化学发光免疫检测技术开发. 生物学杂志, 2019,36(4):85-88.
Zhou Q Y, Huang J R, Chen X, et al. Development of chemiluminescent immunoassay for human serum amyloid A. Journal of Biology, 2019,36(4):85-88.
[14] Huo J Q, Barnych B, Li Z F, et al. Hapten synthesis, antibody development, and a highly sensitive indirect competitive chemiluminescent enzyme immunoassay for detection of dicamba. Journal of Agricultural and Food Chemistry, 2019,67(20):5711-5719.
doi: 10.1021/acs.jafc.8b07134 pmid: 31042038
[15] 何旭华, 徐也鲁, 王振义. 人血栓调节蛋白的分离提纯及其功能特性的初步研究. 浙江医科大学学报, 1988,17(1):1-5.
He X H, Xu Y L, Wang Z Y. Isolation and purification of human thrombomodulin and preliminary study on its functional properties. Journal of Zhejiang Medical University, 1988,17(1):1-5.
[16] 周泉生, 奚晓东, 李佩霞, 等. 一组抗人血栓调节蛋白单克隆抗体的建株. 苏州医学院学报, 1991,11(4):259-261,340.
Zhou Q S, Xi X D, Li P X, et al. Establishment of a group of monoclonal antibodies against human thrombomodulin, Suzhou University Journal of Medical Science, 1991,11(4):259-261,340.
[17] Hosaka Y, Higuchi T, Tsumagari M, et al. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Letters, 2000,161(2):231-240.
pmid: 11090974
[18] Horowitz N A, Blevins E A, Miller W M, et al. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood, 2011,118(10):2889-2895.
[19] Chang Y J, Cheng Y W, Lin R K, et al. Thrombomodulin influences the survival of patients with non-metastatic colorectal cancer through epithelial-to-mesenchymal transition (EMT). PLoS One, 2016,11(8):e0160550.
doi: 10.1371/journal.pone.0160550 pmid: 27512995
[20] Kajioka H, Kagawa S, Ito A, et al. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Letters, 2021,497:1-13.
[21] Karakas M, Baumert J, Herder C, et al. Soluble thrombomodulin in coronary heart disease: lack of an association in the MONICA/KORA case-cohort study. Journal of Thrombosis and Haemostasis, 2011,9(5):1078-1080.
[22] Nakanishi K, Masuda K, Mori N, et al. Evaluation of analytical performance of HISCL TM, a chemiluminescent enzyme immunoassay and the use of thrombomodulin as a marker for endothelial dysfunction. Rinsho byori. The Japanese Journal of Clinical Pathology, 2014,62(10):942-947.
pmid: 27526539
[1] 刘国芳,刘晓志,高健,王志明. 宿主细胞残留蛋白质对单克隆抗体药物质量影响及其质量控制 *[J]. 中国生物工程杂志, 2019, 39(10): 105-110.
[2] 孟迎迎, 姚长洪, 刘娇, 申培丽, 薛松, 杨青. 微藻生物质成分检测方法评述[J]. 中国生物工程杂志, 2017, 37(7): 133-143.
[3] 刘乐庭, 刘爽, 封燕芸, 陈建国, 于常海. NASBA——一种新型禽流感病毒检测方法[J]. 中国生物工程杂志, 2005, 25(11): 96-99.